Zymeworks (ZYME) Accounts Payables (2021 - 2026)
Zymeworks recorded quarterly Accounts Payables of $30.2 million in Q1 2026, down 16.84% quarter-over-quarter from $36.3 million in Q4 2025, and down 20.92% year-over-year from $38.2 million in Q1 2025.
Zymeworks' Accounts Payables history runs 6 years deep, the most recent figure standing at $30.2 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 20.92% year-over-year to $30.2 million; the TTM figure through Mar 2026 stood at $30.2 million (down 20.92% YoY), while the FY2025 annual figure was $36.3 million, down 39.26% from the prior year.
- Accounts Payables came in at $30.2 million for Q1 2026 at Zymeworks, down from $36.3 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $87.5 million in Q4 2022 to a low of $30.2 million in Q1 2026.
- A 5-year average of $50.4 million and a median of $47.4 million in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables jumped 39.3% in 2022 and sank 47.42% in 2023, its largest moves.
- Zymeworks' Accounts Payables stood at $87.5 million in 2022, then sank by 47.42% to $46.0 million in 2023, then soared by 30.11% to $59.8 million in 2024, then plunged by 39.26% to $36.3 million in 2025, then fell by 16.84% to $30.2 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $30.2 million, $36.3 million, and $34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 30.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.23 Mn |
| Dec 31, 2025 | 36.35 Mn |
| Sep 30, 2025 | 34.43 Mn |
| Jun 30, 2025 | 31.00 Mn |
| Mar 31, 2025 | 38.22 Mn |
| Dec 31, 2024 | 59.84 Mn |
| Sep 30, 2024 | 51.71 Mn |
| Jun 30, 2024 | 44.42 Mn |
| Mar 31, 2024 | 47.43 Mn |
| Dec 31, 2023 | 45.99 Mn |
| Sep 30, 2023 | 67.79 Mn |
| Jun 30, 2023 | 69.92 Mn |
| Mar 31, 2023 | 59.25 Mn |
| Dec 31, 2022 | 87.47 Mn |
| Sep 30, 2022 | 52.27 Mn |
| Dec 31, 2021 | 62.79 Mn |